TheBodyPRO.com: The HIV/AIDS Resource for Health Care Professionals

CROI 2018 Coverage on TheBodyPRO
	Read highlights, analyses, and insights from the largest annual HIV research meeting in the U.S.

HIV, Antiretrovirals, and Diabetes
	Despite successful treatment, HIV-positive MSM continue to develop diabetes at an extremely high rate.

Fighting HIV: How to Leave Nobody Behind
	Marsha Martin, D.S.W., discusses how to remove the harm of bias in our response to the HIV epidemic.

Caring for Your Aging Patients With HIV
	We "try to treat every comorbidity they have and don't stop and think whether each medicine's adding additional benefit," says Kristine Erlandson, M.D.

SPOTLIGHT: CARING FOR THE NEWLY DIAGNOSED PATIENT

An ongoing series to help providers set the foundations of a patient's care.

What's New or Notable in HIV Treatment and Prevention Adherence?

Progress and Gaps in Scaling Up Universal HIV Treatment in Africa

Starting HIV Treatment Soon After Diagnosis Trims Time to Viral Suppression

What's the Next Game-Changer in HIV Treatment?

SPOTLIGHT ON HEPATITIS C

The field of hepatitis C disease management is in the midst of dramatic change. This series provides overviews, research updates, and more.

Hepatitis C: How Is It Transmitted and Who Should Be Tested?

Addressing Hepatitis C Treatment Barriers Among HCV/HIV-Coinfected Patients

What Are the Hepatitis C Genotypes?

Hepatitis C Resources, Services and Information

HCV Medications by Drug Class

HIV/AIDS NEWSROOM

HIV "Providers" Aren't Just Doctors: An Interview With Gerald Friedland, M.D.

Roche to Discontinue Supply of Saquinavir (Invirase) 200 mg Capsule for HIV

HCV Cure and the Long Road to Recovery

HCV Treatment in Advanced Liver Disease

Adherence 2018 Panel Tackles Violence and Its Impact on the HIV Care Continuum

This Week in HIV Research: Self-Testing Passes a Big Test

Data Collection Is Revolutionizing HIV Surveillance and Care, but at the Cost of Privacy?

Study Finds High Burden of Psychosocial Issues Among PEP Users

An Overview of Hepatitis C Transmission and Prevention

HIVSmart! App Uses Mobile Technology to Link Self-Testing to Care and Counseling

Today Is the Day: A Call to Action for Providers During LGBTQ Pride Month

Broad PrEP Access in Australia Reduces HIV Infections Even With Reduced Condom Use by People Not on PrEP

Strategies for a Cure

China Approves Albuvirtide: A Once-Weekly Injectable Entry Inhibitor

Is the World Ready for Long-Acting HIV Treatment?

This Week in HIV Research: Monday, Wednesday, Treatment Days

MOST VIEWED ARTICLES

	Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade
	CROI 2018: Highlights and What's Next for Advocates
	Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence
	Injection Drug Use Among People Living With HIV: A Missed Opportunity to Save Lives
	Statin Use Might Reduce Risk of Cancer in HIV-Positive People
	Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say
	Making HIV -- and Bias -- 'Part of the Party' to Strengthen Our Response to the Epidemic
	Who Tends to Gain Weight With HIV Treatment?
	Ibalizumab Phase 3 Results and Susceptibility to Drug-Resistant HIV
	HIV/HCV Coinfection: New Data Has Implications for Treatment-as-Prevention Efforts

More Most Viewed Articles

TheBodyPRO.com is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.